Form 4/A for BHC Bausch Health Companies Inc.
Accepted 2022-10-03 00:00:00 ET · period of report 2022-09-30 · accession 0001127602-22-023292 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2022-10-03 | 2022-09-30 | BHC | Paulson John | Dir | A - Grant | $6.89 | +9,071 | 132.3K | +7% | +$62.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares, No Par Value | 2022-09-30 | A | A | 9,071 | $6.89 | 132,338 | D | — | — | (F1) Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. (F2) This Amended Form 4 is being filed to correct the number of RSUs acquired on September 30, 2022 as reported on the Form 4 filed on October 3, 2022. |